Streetbeat News

Stock Prices

WE

WeWork shares are experiencing volatility and trading higher due to retail investor interest. This comes after the company expressed substantial doubt about its ability to continue operations.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 6:09 pm

BTCUSD

GBTC

Crypto-services provider Matrixport predicts that the U.S. Securities and Exchange Commission (SEC) might approve multiple spot bitcoin exchange-traded funds (ETFs) soon, potentially boosting Bitcoin's value. The SEC is expected to address Grayscale's GBTC lawsuit and the ARK 21Shares Bitcoin ETF reapplication soon, with responses to seven other Bitcoin ETF applications anticipated in early September. Matrixport suggests that a physical Bitcoin ETF might charge a management fee between 0.7% to 1%, potentially generating around $200 million annually for these ETF providers.

Portfolio Pulse from Murtuza Merchant

August 10, 2023 | 6:05 pm

ARKQ

BOTZ

FXI

KWEB

SMH

SOXX

President Joe Biden has signed an executive order restricting certain U.S. investments in China’s key technology sectors, including semiconductors, microelectronics, quantum technology, and specific AI systems. The order aims to prevent U.S. capital and expertise from enhancing China’s military modernization. Analysts at Raymond James suggest that the immediate backlash from China will be limited. The order could potentially tighten if U.S.-China tensions intensify. ETFs with exposure to U.S. and China tech sectors that investors can watch include iShares Semiconductor ETF (SOXX), VanEck Semiconductor ETF (SMH), Global X Robotics and Artificial Intelligence ETF (BOTZ), KraneShares CSI China Internet ETF (KWEB), iShares China Large-Cap ETF (FXI), and ARK Autonomous Technology & Robotics ETF (ARKQ).

Portfolio Pulse from AJ Fabino

August 10, 2023 | 6:04 pm

GSIT

GSI Technology, Inc. (NASDAQ:GSIT) has announced the beta launch of its Copperhead compiler stack, a Python-based tool designed to complement the Gemini APU. The Copperhead suite unlocks the full potential of the Gemini APU's capabilities, allowing developers to create custom frameworks at bit-level granularity. The suite integrates LPython, a user-friendly open-source compiler, and works seamlessly with already available Gemini APU libraries. GSI will be open sourcing the emulation tools of Copperhead to enable community development of applications and libraries for the AI and HPPC markets.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 6:01 pm

EL

A significant amount of unusual options activity has been observed for Estee Lauder Cos (NYSE:EL), with a notably bullish stance. Of the 10 strange trades detected, 70% were opened with bullish expectations and 30% with bearish. Whales have been targeting a price range from $170.0 to $225.0 for Estee Lauder over the last 3 months. The company's stock price is up 2.69% at $170.66. Several financial institutions have recently updated their ratings and price targets for Estee Lauder.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:01 pm

LQDA

In the last quarter, Liquidia (NASDAQ:LQDA) received four bullish ratings and one somewhat bearish rating from analysts. The average 12-month price target for the stock, according to five analysts, is $15.0, a decrease of 16.67% from the previous average price target of $18.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

JAZZ

Jazz Pharmaceuticals (NASDAQ:JAZZ) has received mostly bullish ratings from analysts in the last quarter, with 7 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for the company has increased by 6.15% to $213.89.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

BFRI

Biofrontera (NASDAQ:BFRI) is set to release its latest quarterly earnings report on August 11, 2023. Analysts estimate an earnings per share (EPS) of $-5.14. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. Shares are currently trading at $10.84 and have seen a 63.48% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

ARQT

In the last quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) received 7 bullish ratings from analysts, with an average 12-month price target of $38.14, a decrease of 30.65% from the previous average price target of $55.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm

BALL

Over the past 3 months, 6 analysts have published their opinion on Ball (NYSE:BALL) stock, all of them being indifferent. The average price target is $58.17, implying an upside from the current price of $56.42. The current average has not changed from the previous average price target.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 6:00 pm